Investigational Site 055 — Minneapolis, Minnesota

Investigational Site 055 is a clinical research site located in Minneapolis, Minnesota, United States 55407.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 055 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pericarditis, Pericarditis Acute, Recurrent Pericarditis.

Sponsors: Kiniksa Pharmaceuticals International, plc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 055?

Investigational Site 055 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 055 conducted?

Investigational Site 055 has 1 clinical trials on record, with 1 currently active. Their work covers Pericarditis, Pericarditis Acute, Recurrent Pericarditis.

Is Investigational Site 055 accredited by Crixeo Clinical Trials?

Investigational Site 055 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 055?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.